Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.

Samantha Louise Smith, Sheree Alexander,Nisha Nair,Sebastien Viatte,Stephen Eyre,Kimme L Hyrich,Ann W Morgan,Anthony G Wilson,John D Isaacs,Darren Plant,Anne Barton

Annals of the rheumatic diseases（2023）

引用 1|浏览25

暂无评分

摘要

Beyond correlation with CRP, we found no evidence to suggest that MRP8/14 explains additional variability in response to TNFi in patients with RA over and above CRP alone.

查看译文

关键词

Arthritis, Rheumatoid,Biological Therapy,Tumor Necrosis Factor Inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要